Does hsa-miR-223-3p from platelet-derived extracellular vesicles regulate tissue factor expression in monocytic cells?

References

• Cannell IG, Kong YW, Bushell M. How do microRNAs regulate gene expression? Biochem Soc Trans. 2008;36(6):1224–1231. doi:10.1042/BST0361224.
   PubMedGoogle Scholar
• Diehl P, Fricke A, Sander L, Stamm J, Bassler N, Htun N, Ziemann M, Helbing T, El-Osta A, Jowett JB, et al. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res. 2012;93(4):633–644. doi:10.1093/cvr/cvs007.
   PubMed Web of Science ®Google Scholar
• Shan Z, Qin S, Li W, Wu W, Yang J, Chu M, Li X, Huo Y, Schaer GL, Wang S, et al. An endocrine genetic signal between blood cells and vascular smooth muscle cells: role of MicroRNA-223 in smooth muscle function and atherogenesis. J Am Coll Cardiol. 2015;65(23):2526–2537. doi:10.1016/j.jacc.2015.03.570.
   PubMed Web of Science ®Google Scholar
• Plé H, Landry P, Benham A, Coarfa C, Gunaratne PH, Provost P. The repertoire and features of human platelet microRNAs. PLoS One. 2012;7(12):e50746. doi:10.1371/journal.pone.0050746.
   PubMed Web of Science ®Google Scholar
• Landry P, Plante I, Ouellet DL, Perron MP, Rousseau G, Provost P. Existence of a microRNA pathway in anucleate platelets. Nat Struct Mol Biol. 2009;16(9):961–966. doi:10.1038/nsmb.1651.
   PubMed Web of Science ®Google Scholar
• Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, Kirkby NS, Crosby-Nwaobi R, Prokopi M, Drozdov I, Langley SR, et al. Circulating microRNAs as novel biomarkers for platelet activation. Circ Res. 2013;112(4):595–600. doi:10.1161/CIRCRESAHA.111.300539.
   PubMed Web of Science ®Google Scholar
• Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94(11):3791–3799. doi:10.1182/blood.V94.11.3791.
   PubMed Web of Science ®Google Scholar
• Ambrose AR, Alsahli MA, Kurmani SA, Goodall AH. Comparison of the release of microRNAs and extracellular vesicles from platelets in response to different agonists. Platelets. 2018;29(5):446–454. doi:10.1080/09537104.2017.1332366.
   PubMed Web of Science ®Google Scholar
• Gallo A, Tandon M, Alevizos I, Illei GG. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012;7(3):e30679. doi:10.1371/journal.pone.0030679.
   PubMed Web of Science ®Google Scholar
• Crescitelli R, Lässer C, Szabó TG, Kittel A, Eldh M, Dianzani I, Buzás EI, Lötvall J. Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes. J Extracell Vesicles. 2013;2(1):20677. doi:10.3402/jev.v2i0.20677.
   PubMedGoogle Scholar
• Laffont B, Corduan A, Plé H, Duchez AC, Cloutier N, Boilard E, Provost P. Activated platelets can deliver mRNA regulatory Ago2•microRNA complexes to endothelial cells via microparticles. Blood. 2013;122(2):253–261. doi:10.1182/blood-2013-03-492801.
   PubMed Web of Science ®Google Scholar
• Laffont B, Corduan A, Rousseau M, Duchez AC, Lee CH, Boilard E, Provost P. Platelet microparticles reprogram macrophage gene expression and function. Thromb Haemost. 2016;115(2):311–323. doi:10.1160/th15-05-0389.
   PubMed Web of Science ®Google Scholar
• Bao H, Chen YX, Huang K, Zhuang F, Bao M, Han Y, Chen XH, Shi Q, Yao QP, Qi YX. Platelet-derived microparticles promote endothelial cell proliferation in hypertension via miR-142–3p. FASEB J. 2018;32(7):3912–3923. doi:10.1096/fj.201701073R.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang W, Zha C, Liu Y. Platelets activated by the anti-β2GPI/β2GPI complex release microRNAs to inhibit migration and tube formation of human umbilical vein endothelial cells. Cell Mol Biol Lett. 2018;23(1):24. doi:10.1186/s11658-018-0091-3.
   PubMedGoogle Scholar
• Anene C, Graham AM, Boyne J, Roberts W. Platelet microparticle delivered microRNA-Let-7a promotes the angiogenic switch. Biochim Biophys Acta Mol Basis Dis. 2018;1864(8):2633–2643. doi:10.1016/j.bbadis.2018.04.013.
   PubMed Web of Science ®Google Scholar
• Arraud N, Linares R, Tan S, Gounou C, Pasquet JM, Mornet S, Brisson AR. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration. J Thromb Haemost. 2014;12(5):614–627. doi:10.1111/jth.12554.
   PubMed Web of Science ®Google Scholar
• Hartopo AB, Puspitawati I, Gharini PP, Setianto BY. Platelet microparticle number is associated with the extent of myocardial damage in acute myocardial infarction. Arch Med Sci. 2016;12:529–537. doi:10.5114/aoms.2016.59926.
   PubMed Web of Science ®Google Scholar
• Lukasik M, Rozalski M, Luzak B, Michalak M, Ambrosius W, Watala C, Kozubski W. Enhanced platelet-derived microparticle formation is associated with carotid atherosclerosis in convalescent stroke patients. Platelets. 2013;24(1):63–70. doi:10.3109/09537104.2011.654292.
   PubMed Web of Science ®Google Scholar
• Stępień E, Stankiewicz E, Zalewski J, Godlewski J, Zmudka K, Wybrańska I. Number of microparticles generated during acute myocardial infarction and stable angina correlates with platelet activation. Arch Med Res. 2012;43(1):31–35. doi:10.1016/j.arcmed.2012.01.006.
   PubMed Web of Science ®Google Scholar
• Chiva-Blanch G, Laake K, Myhre P, Bratseth V, Arnesen H, Solheim S, Badimon L, Seljeflot I. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity. PLoS One. 2017;12(2):e0172558. doi:10.1371/journal.pone.0172558.
   PubMed Web of Science ®Google Scholar
• Jung C, Sörensson P, Saleh N, Arheden H, Rydén L, Pernow J. Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction. Atherosclerosis. 2012;221(1):226–231. doi:10.1016/j.atherosclerosis.2011.12.025.
   PubMed Web of Science ®Google Scholar
• Tan KT, Tayebjee MH, Lim HS, Lip GY. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels. Diabet Med. 2005;22(12):1657–1662. doi:10.1111/j.1464-5491.2005.01707.x.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012;60(4):290–299. doi:10.1016/j.jacc.2012.03.056.
   PubMed Web of Science ®Google Scholar
• Li S, Chen H, Ren J, Geng Q, Song J, Lee C, Cao C, Zhang J, Xu N. MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells. Atherosclerosis. 2014;237(2):514–520. doi:10.1016/j.atherosclerosis.2014.09.033.
   PubMed Web of Science ®Google Scholar
• Brand K, Fowler BJ, Edgington TS, Mackman N. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol. 1991;11(9):4732–4738. doi:10.1128/mcb.11.9.4732-4738.1991.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yu H, Lou JR, Zheng J, Zhu H, Popescu NI, Lupu F, Lind SE, Ding WQ. MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J Biol Chem. 2011;286(2):1429–1435. doi:10.1074/jbc.M110.146530.
   PubMed Web of Science ®Google Scholar
• Chuang TD, Luo X, Panda H, Chegini N. miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol. 2012;26(6):1028–1042. doi:10.1210/me.2012-1075.
   PubMedGoogle Scholar
• Witkowski M, Weithauser A, Tabaraie T, Steffens D, Kränkel N, Witkowski M, Stratmann B, Tschoepe D, Landmesser U, Rauch-Kroehnert U. Micro-RNA-126 reduces the blood thrombogenicity in diabetes mellitus via targeting of tissue factor. Arterioscler Thromb Vasc Biol. 2016;36(6):1263–1271. doi:10.1161/ATVBAHA.f115.306094.
   PubMed Web of Science ®Google Scholar
• Sahu A, Jha PK, Prabhakar A, Singh HD, Gupta N, Chatterjee T, Tyagi T, Sharma S, Kumari B, Singh S, et al. MicroRNA-145 impedes thrombus formation via targeting tissue factor in venous thrombosis. EBioMedicine. 2017;26:175–186. doi:10.1016/j.ebiom.2017.11.022.
   PubMed Web of Science ®Google Scholar
• Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol. 1989;9(6):2752–2755. doi:10.1128/mcb.9.6.2752-2755.1989.
   PubMed Web of Science ®Google Scholar
• Oeth P, Parry GC, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-kappa B/Rel, and Sp1 proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vasc Biol. 1997;17(2):365–374. doi:10.1161/01.ATV.17.2.365.
   PubMed Web of Science ®Google Scholar
• Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A. 1994;91(19):8767–8771. doi:10.1073/pnas.91.19.8767.
   PubMed Web of Science ®Google Scholar
• Daigneault M, Preston JA, Marriott HM, Whyte MK, Dockrell DH. The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages. PLoS One. 2010;5(1):e8668. doi:10.1371/journal.pone.0008668.
   PubMed Web of Science ®Google Scholar
• Chung J, Koyama T, Ohsawa M, Shibamiya A, Hoshi A, Hirosawa S. 1,25(OH)(2)D(3) blocks TNF-induced monocytic tissue factor expression by inhibition of transcription factors AP-1 and NF-kappaB. Lab Invest. 2007;87(6):540–547. doi:10.1038/labinvest.3700550.
   PubMed Web of Science ®Google Scholar
• Koyama T, Shibakura M, Ohsawa M, Kamiyama R, Hirosawa S. Anticoagulant effects of 1alpha,25-dihydroxyvitamin D3 on human myelogenous leukemia cells and monocytes. Blood. 1998;92(1):160–167. doi:10.1182/blood.V92.1.160.413k16_160_167.
   PubMed Web of Science ®Google Scholar
• Gardiner C, Ferreira YJ, Dragovic RA, Redman CW, Sargent IL. Extracellular vesicle sizing and enumeration by nanoparticle tracking analysis. J Extracell Vesicles. 2013;2(1):10. doi:10.3402/jev.v2i0.19671.
   Google Scholar
• Collier MEW, Akinmolayan A, Goodall AH. Comparison of tissue factor expression and activity in foetal and adult endothelial cells. Blood Coagul Fibrinolysis. 2017;28(6):452–459. doi:10.1097/MBC.0000000000000621.
   PubMed Web of Science ®Google Scholar
• Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood. 1988;72(1):128–133. doi:10.1182/blood.V72.1.128.bloodjournal721128.
   PubMed Web of Science ®Google Scholar
• Herbert JM, Savi P, Laplace MC, Lale A. IL-4 inhibits LPS-, IL-1 beta- and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett. 1992;310(1):31–33. doi:10.1016/0014-5793(92)81139-D.
   PubMed Web of Science ®Google Scholar
• Pinder PB, Hunt JA, Zacharski LR. In vitro stimulation of monocyte tissue factor activity by autologous platelets. Am J Hematol. 1985;19(4):317–325. doi:10.1002/ajh.2830190402.
   PubMed Web of Science ®Google Scholar
• Witkowski M, Tabaraie T, Steffens D, Friebel J, Dörner A, Skurk C, Witkowski M, Stratmann B, Tschoepe D, Landmesser U, et al. MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes. Cardiovasc Diabetol. 2018;17(1):34. doi:10.1186/s12933-018-0678-z.
   PubMedGoogle Scholar
• Teruel R, Pérez-Sánchez C, Corral J, Herranz MT, Pérez-Andreu V, Saiz E, García-Barberá N, Martínez-Martínez I, Roldán V, Vicente V, et al. Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome. J Thromb Haemost. 2011;9(10):1985–1992. doi:10.1111/j.1538-7836.2011.04451.x.
   PubMed Web of Science ®Google Scholar
• Mandal SK, Pendurthi UR, Rao LV. Cellular localization and trafficking of tissue factor. Blood. 2006;107(12):4746–4753. doi:10.1182/blood-2005-11-4674.
   PubMed Web of Science ®Google Scholar
• Mandal SK, Pendurthi UR, Rao LV. Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling. Blood. 2007;110(1):161–170. doi:10.1182/blood-2006-10-050476.
   PubMed Web of Science ®Google Scholar
• Egorina EM, Sovershaev MA, Bjørkøy G, Gruber FX, Olsen JO, Parhami-Seren B, Mann KG, Østerud B. Intracellular and surface distribution of monocyte tissue factor: application to intersubject variability. Arterioscler Thromb Vasc Biol. 2005;25(7):1493–1498. doi:10.1161/01.ATV.0000168413.29874.d7.
   PubMed Web of Science ®Google Scholar
• Gantier MP, McCoy CE, Rusinova I, Saulep D, Wang D, Xu D, Irving AT, Behlke MA, Hertzog PJ, Mackay F, et al. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res. 2011;39(13):5692–5703. doi:10.1093/nar/gkr148.
   PubMed Web of Science ®Google Scholar
• Guo Y, Liu J, Elfenbein SJ, Ma Y, Zhong M, Qiu C, Ding Y, Lu J. Characterization of the mammalian miRNA turnover landscape. Nucleic Acids Res. 2015;43(4):2326–2341. doi:10.1093/nar/gkv057.
   PubMed Web of Science ®Google Scholar
• Pan Y, Liang H, Liu H, Li D, Chen X, Li L, Zhang CY, Zen K. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J Immunol. 2014;192(1):437–446. doi:10.4049/jimmunol.1301790.
   PubMed Web of Science ®Google Scholar
• Li J, Tan M, Xiang Q, Zhou Z, Yan H. Thrombin-activated platelet-derived exosomes regulate endothelial cell expression of ICAM-1 via microRNA-223 during the thrombosis-inflammation response. Thromb Res. 2017;154:96–105. doi:10.1016/j.thromres.2017.04.016.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Xia L, Fan X, Ostriker AC, Yarovinsky T, Su M, Zhang Y, Peng X, Xie Y, Pi L, et al. Platelet-derived miR-223 promotes a phenotypic switch in arterial injury repair. J Clin Invest. 2019;129(3):1372–1386. doi:10.1172/JCI124508.
   PubMed Web of Science ®Google Scholar
• Tan M, Yan HB, Li JN, Li WK, Fu YY, Chen W, Zhou Z. Thrombin stimulated platelet-derived exosomes inhibit platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells. Cell Physiol Biochem. 2016;38(6):2348–2365. doi:10.1159/000445588.
   PubMedGoogle Scholar
• Li S, Ren J, Xu N, Zhang J, Geng Q, Cao C, Lee C, Song J, Li J, Chen H. MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor. J Mol Cell Cardiol. 2014;75:49–57. doi:10.1016/j.yjmcc.2014.06.017.
   PubMed Web of Science ®Google Scholar
• Lu J, Clark AG. Impact of microRNA regulation on variation in human gene expression. Genome Res. 2012;22(7):1243–1254. doi:10.1101/gr.132514.111.
   PubMed Web of Science ®Google Scholar
• Hayon Y, Dashevsky O, Shai E, Varon D, Leker RR. Platelet microparticles promote neural stem cell proliferation, survival and differentiation. J Mol Neurosci. 2012;47(3):659–665. doi:10.1007/s12031-012-9711-y.
   PubMed Web of Science ®Google Scholar
• Kim HK, Song KS, Chung JH, Lee KR, Lee SN. Platelet microparticles induce angiogenesis in vitro. Br J Haematol. 2004;124(3):376–384. doi:10.1046/j.1365-2141.2003.04773.x.
   PubMed Web of Science ®Google Scholar
• Risitano A, Beaulieu LM, Vitseva O, Freedman JE. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood. 2012;119(26):6288–6295. doi:10.1182/blood-2011-12-396440.
   PubMed Web of Science ®Google Scholar
• Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008;3(11):e3694. doi:10.1371/journal.pone.0003694.
   PubMed Web of Science ®Google Scholar
• Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, Ebeling M, Badi L, Reis B, Bitter H, D’Asaro M, et al. Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One. 2012;7(1):e29979. doi:10.1371/journal.pone.0029979.
   PubMed Web of Science ®Google Scholar